Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
All price changes →Indications & Uses
Tresiba is indicated for:
Pharmacology
Insulin Degludec, like all insulins, works mainly by regulating glucose metabolism. Insulin and its analogues lower blood glucose in two ways. They stimulate peripheral glucose uptake, especially by skeletal muscle and fat, and they inhibit hepatic glucose production. Insulin also inhibits lipolysis and proteolysis, and it enhances protein synthesis.
When Insulin Degludec is injected into the subcutaneous tissue, it forms multihexamers. These make a subcutaneous insulin degludec depot under the skin. The protracted time action profile of Insulin Degludec is mostly due to delayed absorption of insulin degludec from the subcutaneous tissue into the systemic circulation. To a lesser extent, it is due to the binding of insulin degludec to circulating albumin.
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Insulin Degludec is an ultra long-acting basal insulin, given once a day at any time of the day, though it's best to use the same time every day. For patients with type 2 diabetes mellitus, the recommended starting dose is 10 units a day, and the dose is then adjusted for each person. For patients with type 1 diabetes mellitus, it is used once a day together with mealtime insulin, and it also needs individual dose adjustments after that. In type 2 diabetes mellitus, it can be given alone or in any combination with oral anti-diabetic medicines, GLP-1 receptor agonists and bolus insulin. In type 1 diabetes mellitus, it must be combined with short-acting or rapid-acting insulin to cover mealtime insulin needs. If giving the injection at the same time each day isn't possible, Insulin Degludec allows some flexibility in timing, but there should always be at least 8 hours between injections. A patient who forgets a dose is advised to take it as soon as they find out, and then go back to the usual once-daily schedule.
Side Effects
Insulin Degludec can cause nasopharyngitis, upper respiratory tract infection, sinusitis, headache, diarrhea and gastroenteritis. Injection site reactions and peripheral edema can also happen. A severe hypoglycemic episode is another possible side effect.
Cautions & Contraindications
Warnings & Precautions
Tresibas must not be injected into a vein (intravenously) or into a muscle (intramuscularly), and it must not be used in infusion pumps. There is no experience with Insulin Degludec in children and adolescents under 18 years of age.
Pregnancy & Breastfeeding
Pregnant women: There is no clinical experience from well-controlled studies of Insulin degludec in pregnant women. Animal reproduction studies have not shown any difference between insulin degludec and human insulin in embryotoxicity or teratogenicity. But animal studies don't always predict how humans will respond, so Insulin degludec should not be used during pregnancy unless the possible benefit to the mother justifies the possible risk to the fetus.
Nursing women: There is no clinical experience from well-controlled studies of insulin degludec during breastfeeding. It is not known whether insulin degludec passes into human milk. In rats, insulin degludec was secreted in milk, and the concentration in milk was lower than the concentration in plasma.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Use in Special Populations
Geriatrics (65 years of age or older): Doctors have not seen any overall difference in safety or effectiveness of Insulin Degludec between elderly patients and adult patients.
Pediatrics (under 18 years of age): Insulin Degludec is not indicated for use in children and adolescents.
Drug Interactions
Common questions about Tresiba 100 IU/ml
What is Tresiba 100 IU/ml SC Injection?
Tresiba 100 IU/ml SC Injection is a medicine that contains Insulin Degludec. It is made by Novo Nordisk Pharma (Pvt.) Ltd. It belongs to the Long Acting Insulin group of medicines.
What is Tresiba used for?
Tresiba is used for: Diabetes Mellitus.
What are the side effects of Tresiba?
Insulin Degludec can cause nasopharyngitis, upper respiratory tract infection, sinusitis, headache, diarrhea and gastroenteritis. Injection site reactions and peripheral edema can also happen.
Can I take Tresiba during pregnancy or while breastfeeding?
Pregnant women: There is no clinical experience from well-controlled studies of Insulin degludec in pregnant women. Animal reproduction studies have not shown any difference between insulin degludec and human insulin in embryotoxicity or teratogenicity. Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Can I take other medicines with Tresiba?
Some medicines can interact with Insulin Degludec, for example: Pioglitazone, Isoniazid, Rosiglitazone, Disopyramide, Somatropin, Clozapine. Tell your doctor or pharmacist about every medicine you take.
Do I need a prescription for Tresiba?
Tresiba is a prescription (Rx) medicine. Take it as your doctor advises.